4-Methyl-α-methyltryptamine

4-Methyl-α-methyltryptamine
Clinical data
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	Uncontrolled (but may be covered under the Federal Analogue Act in the United States and under similar bills in other countries);
Identifiers
	IUPAC name 1-methyl-2-(4-methyl-1H-indol-3-yl)-ethylamine;
CAS Number	3569-29-7 ;
PubChem CID	28806639;
ChemSpider	25392939 ;
UNII	QY99ES7YWD;
CompTox Dashboard (EPA)	DTXSID70708203 ;
Chemical and physical data
Formula	C12H16N2
Molar mass	188.274 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(N)Cc2c1c([nH]c2)cccc1C;
	InChI InChI=1S/C12H16N2/c1-8-4-3-5-11-12(8)10(7-14-11)6-9(2)13/h3-5,7,9,14H,6,13H2,1-2H3 ; Key:KEOYEGHPRBDSKD-UHFFFAOYSA-N ;
	(verify)

4-Methyl-α-methyltryptamine (4-Me-αMT), also known as 4,α-dimethyltryptamine (4,α-DMT), and MP-809, is a drug belonging to the tryptamine class that was investigated as an antidepressant in the early 1960s but was never marketed.^[1]^[2]

References

^ Azima H, Arthurs D, Silver A, Azima FJ (December 1962). "The effect of MP-809 in depressive states: a multi-blind study". The American Journal of Psychiatry. 119 (6): 573–4. doi:10.1176/ajp.119.6.573. PMID 13965759.
^ Brodey JF, Steiner WG, Himwich HE (April 1963). "An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809)". The Journal of Pharmacology and Experimental Therapeutics. 140: 8–18. PMID 14015664.

[pmid13965759-1] Azima H, Arthurs D, Silver A, Azima FJ (December 1962). "The effect of MP-809 in depressive states: a multi-blind study". The American Journal of Psychiatry. 119 (6): 573–4. doi:10.1176/ajp.119.6.573. PMID 13965759.

[2] Brodey JF, Steiner WG, Himwich HE (April 1963). "An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809)". The Journal of Pharmacology and Experimental Therapeutics. 140: 8–18. PMID 14015664.

[1]

[2]

See also

References